Solid tumor Clinical Trials in New York, NY

As of July 2026, 138 paid clinical trials are recruiting for Solid tumor in New York, New York. Recruiting Solid tumor studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 16, 2026.

Related specialties in New York

Oncology· 1,442

Filter results

Filter results

State

City

Facility

Phase

Study type

Intervention

Recruitment status

Condition

Sex

Age

Healthy volunteers only

138 clinical trials for Solid tumor

·Clear filters·↓ Download CSV

A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors

for Wilms Tumor

Drug: Selinexor

16 locations incl. Los Angeles

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All·Age: 12 Months+

Code: NCT05985161·Phase 2·Recruiting

Apply to this trial

Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers

for Anal Carcinoma

8 locations incl. La Jolla

Sponsor: AIDS Malignancy Consortium

Sex: All·Age: 18+

Code: NCT05663502·Recruiting

Apply to this trial

Remote Digital Physiologic Data Collection in Cancer: An MSK Registry Protocol

for Solid Tumor

1 location in New York

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT05390827·Recruiting

Apply to this trial

A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue

for Invasive Ductal Breast Carcinoma

7 locations incl. Basking Ridge

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All·Age: 18+

Code: NCT05837767·Recruiting

Apply to this trial

A Study of Repotrectinib in Combination With Chemotherapy in Children and Young Adults With Solid Tumor Cancer

for Advanced Cancer

Drug: Repotrectinib

1 location in New York

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All·Age: 1 - 25

Code: NCT05004116·Phase 1, Phase 2·Recruiting

Apply to this trial

A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer

for Cutaneous Squamous Cell Carcinoma

7 locations incl. Basking Ridge

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All·Age: 18+

Code: NCT05859074·Phase 1·Recruiting

Apply to this trial

Psychotherapy Intervention for Latinos With Adv Cancer

for Solid Tumor

3 locations incl. New York

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT04537936·Recruiting

Apply to this trial

Psychotherapy Intervention for Latinos With Advanced Cancer

for Solid Tumor

3 locations incl. New York

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT04015609·Recruiting

Apply to this trial

Personalized Models for Cancer Research

for Solid Tumor, Adult

1 location in New York

Sponsor: New York Stem Cell Foundation Research Institute

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT06350539·Recruiting

Apply to this trial

First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors

for Esophageal Squamous Cell Carcinoma

10 locations incl. Scottsdale

Sponsor: Plexium, Inc.

Sex: All·Age: 18+

Code: NCT07284186·Phase 1·Recruiting

Apply to this trial

A Study of XB628 Alone and in Combination With Zanzalintinib in Participants With Recurrent Advanced or Metastatic Solid Tumors

for Solid Tumor

11 locations incl. San Francisco

Sponsor: Exelixis

Sex: All·Age: 18+

Code: NCT06952010·Phase 1·Recruiting

Apply to this trial

A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)

for Solid Tumors

18 locations incl. Birmingham

Sponsor: GlaxoSmithKline

Sex: All·Age: 18+

Code: NCT06431594·Phase 1·Recruiting

Apply to this trial

Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors

for Non-small Cell Lung Cancer

18 locations incl. Duarte

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT06218914·Phase 1·Recruiting

Apply to this trial

A Phase 1/2 Study of BHV-1510 (Previously PBI-410) in Advanced Solid Tumors

for Solid Tumor

17 locations incl. Duarte

Sponsor: Biohaven Therapeutics Ltd.

Sex: All·Age: 18+

Code: NCT06384807·Phase 1, Phase 2·Recruiting

Apply to this trial

Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid Tumors

for Renal Cell Carcinoma (RCC)

46 locations incl. Phoenix

Sponsor: Exelixis

Sex: All·Age: 18+

Code: NCT05176483·Phase 1·Recruiting

Apply to this trial

A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors

for Clear Cell Renal Cell Carcinoma

20 locations incl. Birmingham

Sponsor: Arcus Biosciences, Inc.

Sex: All·Age: 18+

Code: NCT05536141·Phase 1·Recruiting

Apply to this trial

A Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer

for Solid Tumor

8 locations incl. Aurora

Sponsor: K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc

Sex: Female·Age: 18+

Code: NCT04516447·Phase 1·Recruiting

Apply to this trial

A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors

for Advanced Solid Tumor

16 locations incl. Fountain Valley

Sponsor: Exelixis

Sex: All·Age: 18+

Code: NCT05932862·Phase 1·Recruiting

Apply to this trial